INCLISIRAN

INCLISIRAN was reported 8446 times

These side effects are most commonly reported by patients taking INCLISIRAN:

# Side effect Count
0 ARTHRALGIA 908
1 MYALGIA 706
2 INJECTION SITE PAIN 600
3 LOW DENSITY LIPOPROTEIN INCREASED 529
4 PAIN IN EXTREMITY 510
5 DRUG INEFFECTIVE 442
6 FATIGUE 440
7 PAIN 423
8 DIARRHOEA 389
9 DYSPNOEA 375
10 HEADACHE 330
11 RASH 299
12 MUSCLE SPASMS 268
13 DIZZINESS 251
14 COUGH 248
15 BACK PAIN 237
16 NAUSEA 236
17 BLOOD CHOLESTEROL INCREASED 234
18 PRURITUS 228
19 PRODUCT STORAGE ERROR 219
20 INJECTION SITE REACTION 215
21 MALAISE 212
22 INJECTION SITE RASH 198
23 BLOOD TRIGLYCERIDES INCREASED 197
24 URINARY TRACT INFECTION 193
25 INJECTION SITE ERYTHEMA 187
26 ASTHENIA 180
27 BLOOD GLUCOSE INCREASED 165
28 CHEST PAIN 161
29 HYPERSENSITIVITY 158
30 MYOCARDIAL INFARCTION 156
31 GAIT DISTURBANCE 148
32 DEATH 142
33 BRONCHITIS 141
34 NASOPHARYNGITIS 141
35 INJECTION SITE PRURITUS 137
36 WEIGHT DECREASED 130
37 DRUG INTOLERANCE 129
38 ABDOMINAL DISCOMFORT 126
39 FEELING ABNORMAL 126
40 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 119
41 PERIPHERAL SWELLING 117
42 HYPERTENSION 112
43 INSOMNIA 111
44 MUSCULAR WEAKNESS 110
45 ILLNESS 109
46 OFF LABEL USE 106
47 ABDOMINAL PAIN UPPER 103
48 INFLUENZA LIKE ILLNESS 103
49 ARTHRITIS 102
50 LOW DENSITY LIPOPROTEIN DECREASED 102
51 ERYTHEMA 101
52 DIABETES MELLITUS 99
53 COVID-19 97
54 PYREXIA 97
55 THERAPY NON-RESPONDER 96
56 LOWER RESPIRATORY TRACT INFECTION 94
57 URTICARIA 94
58 GENERAL PHYSICAL HEALTH DETERIORATION 92
59 CEREBROVASCULAR ACCIDENT 91
60 MEMORY IMPAIRMENT 90
61 PNEUMONIA 90
62 VOMITING 87
63 ALANINE AMINOTRANSFERASE INCREASED 84
64 ALOPECIA 84
65 HYPOAESTHESIA 84
66 BLOOD CHOLESTEROL DECREASED 83
67 BLOOD PRESSURE INCREASED 83
68 MUSCULOSKELETAL STIFFNESS 81
69 CHEST DISCOMFORT 80
70 FALL 80
71 HEPATIC ENZYME INCREASED 80
72 INJECTION SITE SWELLING 79
73 CONSTIPATION 77
74 PRODUCT DOSE OMISSION ISSUE 75
75 ASPARTATE AMINOTRANSFERASE INCREASED 74
76 PARAESTHESIA 74
77 ABDOMINAL PAIN 71
78 OROPHARYNGEAL PAIN 68
79 RHINORRHOEA 68
80 BURNING SENSATION 67
81 PRODUCT USE IN UNAPPROVED INDICATION 67
82 GLYCOSYLATED HAEMOGLOBIN INCREASED 65
83 ANGINA PECTORIS 62
84 WEIGHT INCREASED 62
85 BONE PAIN 61
86 CONTUSION 61
87 ATRIAL FIBRILLATION 60
88 ACUTE MYOCARDIAL INFARCTION 58
89 INJECTION SITE BRUISING 57
90 NEUROPATHY PERIPHERAL 57
91 CHILLS 56
92 INFLUENZA 56
93 SYNCOPE 56
94 BLOOD CREATINE PHOSPHOKINASE INCREASED 55
95 HIGH DENSITY LIPOPROTEIN DECREASED 55
96 LIMB DISCOMFORT 55
97 ANXIETY 54
98 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 54
99 DISCOMFORT 53
100 NASAL CONGESTION 52
101 GAMMA-GLUTAMYLTRANSFERASE INCREASED 51
102 JOINT SWELLING 51
103 MOVEMENT DISORDER 51
104 NECK PAIN 50
105 HYPOACUSIS 49
106 PALPITATIONS 49
107 MOBILITY DECREASED 48
108 SWELLING 48
109 HYPOTENSION 47
110 VERTIGO 47
111 CONDITION AGGRAVATED 46
112 VISION BLURRED 46
113 CARDIAC DISORDER 45
114 PRODUCTIVE COUGH 45
115 DECREASED APPETITE 44
116 GASTROINTESTINAL DISORDER 44
117 HYPERHIDROSIS 44
118 SINUSITIS 44
119 ABDOMINAL DISTENSION 43
120 LIPOPROTEIN (A) INCREASED 43
121 LOSS OF CONSCIOUSNESS 42
122 BLOOD CHOLESTEROL ABNORMAL 41
123 CORONARY ARTERY DISEASE 41
124 DEPRESSION 41
125 VISUAL IMPAIRMENT 41
126 ARTERIOSCLEROSIS 40
127 BLOOD URIC ACID INCREASED 40
128 NEURALGIA 40
129 TREMOR 40
130 MUSCULOSKELETAL DISCOMFORT 39
131 DRUG EFFECT LESS THAN EXPECTED 38
132 DRUG HYPERSENSITIVITY 38
133 POLLAKIURIA 38
134 C-REACTIVE PROTEIN INCREASED 37
135 HIGH DENSITY LIPOPROTEIN INCREASED 37
136 PERIPHERAL ARTERIAL OCCLUSIVE DISEASE 37
137 SLEEP DISORDER 37
138 LIVER FUNCTION TEST INCREASED 36
139 SWELLING FACE 36
140 SWOLLEN TONGUE 36
141 ARRHYTHMIA 35
142 HAEMORRHAGE 35
143 INJECTION SITE DISCOMFORT 35
144 LETHARGY 35
145 DIVERTICULITIS 34
146 DYSPEPSIA 34
147 LOW DENSITY LIPOPROTEIN ABNORMAL 34
148 MYOPATHY 34
149 CORONARY ARTERY STENOSIS 33
150 PRODUCT TEMPERATURE EXCURSION ISSUE 33
151 BLISTER 32
152 MUSCLE TWITCHING 32
153 SOMNOLENCE 32
154 ADVERSE DRUG REACTION 31
155 BLOOD CREATININE INCREASED 31
156 DYSPHAGIA 31
157 HEART RATE INCREASED 31
158 INFLAMMATION 31
159 SPEECH DISORDER 31
160 BALANCE DISORDER 30
161 CATARACT 30
162 GAIT INABILITY 29
163 INJECTION SITE WARMTH 29
164 RHEUMATOID ARTHRITIS 29
165 CREATINE KINASE INCREASED 28
166 FIBROMYALGIA 28
167 LABORATORY TEST ABNORMAL 28
168 RASH PRURITIC 28
169 BRAIN FOG 27
170 CARDIAC FAILURE 27
171 CONFUSIONAL STATE 27
172 DRY SKIN 27
173 DYSSTASIA 27
174 JOINT STIFFNESS 27
175 LIP SWELLING 27
176 MIGRAINE 27
177 NEOPLASM MALIGNANT 27
178 ARTHROPATHY 26
179 ASTHMA 26
180 DYSURIA 26
181 HEPATIC FUNCTION ABNORMAL 26
182 HOT FLUSH 26
183 INJECTION SITE MASS 26
184 PAIN IN JAW 26
185 PANCREATITIS 26
186 ANAPHYLACTIC REACTION 25
187 BLOOD PRESSURE DECREASED 25
188 CORONAVIRUS INFECTION 25
189 FEELING HOT 25
190 INJECTION SITE DISCOLOURATION 25
191 LIVER INJURY 25
192 THROMBOSIS 25
193 AMNESIA 24
194 DEHYDRATION 24
195 ACUTE KIDNEY INJURY 23
196 FEELING COLD 23
197 HAEMATOMA 23
198 INFECTION 23
199 RENAL IMPAIRMENT 23
200 COLD SWEAT 22
201 CORONARY ARTERY OCCLUSION 22
202 INJECTION SITE VESICLES 22
203 PULMONARY CONGESTION 22
204 SKIN EXFOLIATION 22
205 ACUTE CORONARY SYNDROME 21
206 DYSPHONIA 21
207 GASTROINTESTINAL PAIN 21
208 ILL-DEFINED DISORDER 21
209 IMMUNE SYSTEM DISORDER 21
210 LIPIDS INCREASED 21
211 NEPHROLITHIASIS 21
212 OXYGEN SATURATION DECREASED 21
213 RASH MACULAR 21
214 BLOOD ALKALINE PHOSPHATASE INCREASED 20
215 DISEASE PROGRESSION 20
216 FLATULENCE 20
217 HEPATIC STEATOSIS 20
218 INDURATION 20
219 LIVER DISORDER 20
220 OEDEMA PERIPHERAL 20
221 STRESS 20
222 ADVERSE REACTION 19
223 ANGINA UNSTABLE 19
224 DEAFNESS 19
225 DRY MOUTH 19
226 EYE PAIN 19
227 HYPERKALAEMIA 19
228 RENAL FAILURE 19
229 THERAPEUTIC PRODUCT EFFECT DECREASED 19
230 THROAT IRRITATION 19
231 TYPE 2 DIABETES MELLITUS 19
232 ANGIOEDEMA 18
233 BLOOD PRESSURE ABNORMAL 18
234 CHRONIC KIDNEY DISEASE 18
235 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 18
236 HEART RATE DECREASED 18
237 OSTEOARTHRITIS 18
238 PULMONARY EMBOLISM 18
239 RASH ERYTHEMATOUS 18
240 SINUS DISORDER 18
241 SKIN DISCOLOURATION 18
242 SPINAL PAIN 18
243 SPINAL STENOSIS 18
244 TINNITUS 18
245 BLOOD GLUCOSE ABNORMAL 17
246 CONCOMITANT DISEASE AGGRAVATED 17
247 FLUSHING 17
248 HEPATITIS 17
249 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 17
250 MYOCARDIAL ISCHAEMIA 17
251 PANIC ATTACK 17
252 RESTLESSNESS 17
253 TRANSIENT ISCHAEMIC ATTACK 17
254 WHEEZING 17
255 BLOOD GLUCOSE DECREASED 16
256 COLITIS 16
257 DIABETES MELLITUS INADEQUATE CONTROL 16
258 DRUG INTERACTION 16
259 EPISTAXIS 16
260 GOUT 16
261 INCORRECT DOSE ADMINISTERED 16
262 LERICHE SYNDROME 16
263 MENTAL DISORDER 16
264 MORPHOEA 16
265 RENAL DISORDER 16
266 TACHYCARDIA 16
267 UPPER RESPIRATORY TRACT INFECTION 16
268 WAIST CIRCUMFERENCE INCREASED 16
269 BLOOD PRESSURE FLUCTUATION 15
270 HEPATIC FIBROSIS 15
271 HYPOGLYCAEMIA 15
272 INJECTION SITE HYPERSENSITIVITY 15
273 INJECTION SITE IRRITATION 15
274 JAUNDICE 15
275 MITRAL VALVE INCOMPETENCE 15
276 SKIN BURNING SENSATION 15
277 SKIN REACTION 15
278 SNEEZING 15
279 APHASIA 14
280 BACK DISORDER 14
281 BREAST CANCER 14
282 CELLULITIS 14
283 CHOLESTASIS 14
284 CYSTITIS 14
285 DRUG-INDUCED LIVER INJURY 14
286 DYSARTHRIA 14
287 ERECTILE DYSFUNCTION 14
288 GASTROOESOPHAGEAL REFLUX DISEASE 14
289 GLOMERULAR FILTRATION RATE DECREASED 14
290 HAEMATOCHEZIA 14
291 HEAD DISCOMFORT 14
292 INTERVERTEBRAL DISC DISORDER 14
293 LYMPHADENOPATHY 14
294 MUSCLE ATROPHY 14
295 MUSCLE DISCOMFORT 14
296 MUSCLE DISORDER 14
297 OEDEMA 14
298 PANCREATIC CARCINOMA 14
299 RESPIRATORY DISORDER 14
300 VASCULAR STENT STENOSIS 14
301 ABDOMINAL PAIN LOWER 13
302 CEREBRAL INFARCTION 13
303 DEMENTIA 13
304 DYSGEUSIA 13
305 ECZEMA 13
306 EYE IRRITATION 13
307 INJURY ASSOCIATED WITH DEVICE 13
308 IRRITABLE BOWEL SYNDROME 13
309 MUSCLE FATIGUE 13
310 OROPHARYNGEAL DISCOMFORT 13
311 PHARYNGEAL SWELLING 13
312 SEIZURE 13
313 TENDON PAIN 13
314 THERAPEUTIC RESPONSE DECREASED 13
315 THROAT TIGHTNESS 13
316 APOLIPOPROTEIN B DECREASED 12
317 BLOOD SODIUM DECREASED 12
318 BLOOD TRIGLYCERIDES ABNORMAL 12
319 BLOOD URINE PRESENT 12
320 DYSLIPIDAEMIA 12
321 FLUID RETENTION 12
322 FOOT DEFORMITY 12
323 FUNGAL INFECTION 12
324 HAEMOGLOBIN DECREASED 12
325 HEART RATE IRREGULAR 12
326 HIGH DENSITY LIPOPROTEIN ABNORMAL 12
327 HYPONATRAEMIA 12
328 INFARCTION 12
329 ISCHAEMIC NEPHROPATHY 12
330 MYOSITIS 12
331 PARAESTHESIA ORAL 12
332 POOR QUALITY SLEEP 12
333 PROTEIN TOTAL INCREASED 12
334 RESPIRATORY TRACT INFECTION 12
335 SKIN ULCER 12
336 TENDON RUPTURE 12
337 TENDONITIS 12
338 WHITE BLOOD CELL COUNT INCREASED 12
339 APHONIA 11
340 APOLIPOPROTEIN B INCREASED 11
341 BLINDNESS 11
342 BLOOD ALBUMIN DECREASED 11
343 BLOOD PRESSURE SYSTOLIC INCREASED 11
344 BLOOD THYROID STIMULATING HORMONE INCREASED 11
345 BLOOD TRIGLYCERIDES DECREASED 11
346 CHROMATURIA 11
347 DEEP VEIN THROMBOSIS 11
348 DEHISCENCE 11
349 DYSPNOEA EXERTIONAL 11
350 FAECES DISCOLOURED 11
351 HALLUCINATION 11
352 HERPES ZOSTER 11
353 INJECTION SITE URTICARIA 11
354 MUSCLE RIGIDITY 11
355 MUSCULOSKELETAL CHEST PAIN 11
356 OSTEOPOROSIS 11
357 PROSTATE CANCER 11
358 PULMONARY OEDEMA 11
359 SECRETION DISCHARGE 11
360 SKIN IRRITATION 11
361 SPLEEN ISCHAEMIA 11
362 TASTE DISORDER 11
363 ULNAR NERVE INJURY 11
364 URINARY RETENTION 11
365 VIRAL INFECTION 11
366 WOUND 11
367 ABSCESS 10
368 AORTIC ANEURYSM 10
369 ATRIOVENTRICULAR BLOCK COMPLETE 10
370 AUTOIMMUNE DISORDER 10
371 CARDIAC ARREST 10
372 CHOKING 10
373 DEPRESSED MOOD 10
374 DISCHARGE 10
375 DISEASE RECURRENCE 10
376 EXERCISE TOLERANCE DECREASED 10
377 GASTROINTESTINAL HAEMORRHAGE 10
378 GLUCOSE TOLERANCE IMPAIRED 10
379 HYPERLIPIDAEMIA 10
380 HYPOTHYROIDISM 10
381 INJECTION SITE INFLAMMATION 10
382 MIDDLE INSOMNIA 10
383 MUSCLE TIGHTNESS 10
384 NEEDLE ISSUE 10
385 NERVOUS SYSTEM DISORDER 10
386 NIGHTMARE 10
387 PERIPHERAL ARTERY BYPASS 10
388 PRESYNCOPE 10
389 PRODUCT DOSE OMISSION IN ERROR 10
390 PSORIASIS 10
391 RENAL PAIN 10
392 RESPIRATORY TRACT CONGESTION 10
393 SCAR 10
394 SENSORY DISTURBANCE 10
395 SEPSIS 10
396 SKIN DISORDER 10
397 TENDERNESS 10
398 VITAMIN D DEFICIENCY 10
399 ARTERIAL OCCLUSIVE DISEASE 9
400 ARTERIOSCLEROSIS CORONARY ARTERY 9
401 BLOOD CREATINE PHOSPHOKINASE MB INCREASED 9
402 BLOOD UREA INCREASED 9
403 BODY TEMPERATURE INCREASED 9
404 BOWEL MOVEMENT IRREGULARITY 9
405 CARDIAC FAILURE ACUTE 9
406 CARDIAC FAILURE CONGESTIVE 9
407 CEREBRAL HAEMORRHAGE 9
408 DISORIENTATION 9
409 DISTURBANCE IN ATTENTION 9
410 DRY EYE 9
411 EATING DISORDER 9
412 EYE SWELLING 9
413 FEAR OF DEATH 9
414 HEPATIC PAIN 9
415 HYPERGLYCAEMIA 9
416 IMMOBILE 9
417 IMMOBILISATION SYNDROME 9
418 IMPAIRED HEALING 9
419 LARYNGITIS 9
420 LIPASE INCREASED 9
421 LUNG DISORDER 9
422 LUNG NEOPLASM MALIGNANT 9
423 MUCOSAL INFLAMMATION 9
424 OCULAR HYPERAEMIA 9
425 PANCYTOPENIA 9
426 PERIPHERAL ARTERY OCCLUSION 9
427 POLYNEUROPATHY 9
428 PROTEIN URINE PRESENT 9
429 RESTLESS LEGS SYNDROME 9
430 RHABDOMYOLYSIS 9
431 SCIATICA 9
432 THROMBOCYTOPENIA 9
433 TROPONIN INCREASED 9
434 ANAPHYLACTIC SHOCK 8
435 ATRIOVENTRICULAR BLOCK 8
436 CAROTID ARTERY STENOSIS 8
437 CHRONIC HEPATITIS C 8
438 COGNITIVE DISORDER 8
439 DRY THROAT 8
440 EAR PAIN 8
441 GLOMERULONEPHRITIS 8
442 GLYCOSYLATED HAEMOGLOBIN 8
443 GRAFT COMPLICATION 8
444 HAEMATEMESIS 8
445 HYPERTHYROIDISM 8
446 HYPOKINESIA 8
447 LIPIDS ABNORMAL 8
448 LOW DENSITY LIPOPROTEIN 8
449 METASTASES TO BONE 8
450 MUSCLE RUPTURE 8
451 MYASTHENIA GRAVIS 8
452 NEPHROTIC SYNDROME 8
453 NERVOUSNESS 8
454 NON-HIGH-DENSITY LIPOPROTEIN CHOLESTEROL INCREASED 8
455 OVERWEIGHT 8
456 PARALYSIS 8
457 PARKINSON^S DISEASE 8
458 PERICARDITIS 8
459 PERIPHERAL ISCHAEMIA 8
460 PROTEINURIA 8
461 QUALITY OF LIFE DECREASED 8
462 RENAL HYPERTENSION 8
463 RENAL INFARCT 8
464 RESPIRATORY DISTRESS 8
465 RESPIRATORY FAILURE 8
466 RETICULOCYTE COUNT INCREASED 8
467 RIB FRACTURE 8
468 SCAB 8
469 SKIN LESION 8
470 SLEEP APNOEA SYNDROME 8
471 STENOSIS 8
472 TREATMENT FAILURE 8
473 URINE PROTEIN/CREATININE RATIO INCREASED 8
474 VASCULITIS 8
475 WOUND COMPLICATION 8
476 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 8
477 ACCIDENTAL EXPOSURE TO PRODUCT 7
478 ANAEMIA 7
479 ASPIRATION 7
480 BACK INJURY 7
481 BLOOD POTASSIUM DECREASED 7
482 BRADYCARDIA 7
483 CARDIAC DISCOMFORT 7
484 CARDIAC FLUTTER 7
485 CHOLELITHIASIS 7
486 DERMATITIS CONTACT 7
487 DRUG DOSE OMISSION BY DEVICE 7
488 FOOT FRACTURE 7
489 HAEMOPTYSIS 7
490 HEPATIC CIRRHOSIS 7
491 HYPERSOMNIA 7
492 HYPERTENSIVE CRISIS 7
493 HYPOAESTHESIA ORAL 7
494 INJECTION SITE HAEMORRHAGE 7
495 INJECTION SITE NODULE 7
496 INJURY 7
497 LACRIMATION INCREASED 7
498 LIPIDS DECREASED 7
499 LIVER FUNCTION TEST ABNORMAL 7
500 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 7
501 NECROSIS 7
502 OBSTRUCTIVE SLEEP APNOEA SYNDROME 7
503 PLATELET COUNT DECREASED 7
504 PRODUCT AVAILABILITY ISSUE 7
505 PRODUCT PRESCRIBING ERROR 7
506 PRODUCT USE ISSUE 7
507 PULMONARY MASS 7
508 RECTAL HAEMORRHAGE 7
509 SPLENIC INFARCTION 7
510 SYSTEMIC LUPUS ERYTHEMATOSUS 7
511 TOOTHACHE 7
512 TRANSAMINASES INCREASED 7
513 TYPE IIA HYPERLIPIDAEMIA 7
514 UNEVALUABLE EVENT 7
515 UPPER-AIRWAY COUGH SYNDROME 7
516 VENTRICULAR ARRHYTHMIA 7
517 VERY LOW DENSITY LIPOPROTEIN INCREASED 7
518 APATHY 6
519 AUTOIMMUNE MYOSITIS 6
520 BLOOD BILIRUBIN INCREASED 6
521 BREAST PAIN 6
522 BRONCHOSPASM 6
523 BURSITIS 6
524 CARDIAC DYSFUNCTION 6
525 CIRCULATORY COLLAPSE 6
526 CRYING 6
527 DEMENTIA ALZHEIMER^S TYPE 6
528 DERMATITIS 6
529 DYSKINESIA 6
530 EAR INFECTION 6
531 EMOTIONAL DISTRESS 6
532 EYE DISORDER 6
533 EYE HAEMORRHAGE 6
534 FEEDING DISORDER 6
535 FREQUENT BOWEL MOVEMENTS 6
536 GASTROENTERITIS VIRAL 6
537 HEAD INJURY 6
538 HEMIPARESIS 6
539 HERNIA 6
540 HYPERTRIGLYCERIDAEMIA 6
541 HYPOPHAGIA 6
542 HYPOPNOEA 6
543 IMMUNE-MEDIATED MYOSITIS 6
544 IMMUNODEFICIENCY 6
545 INCREASED APPETITE 6
546 INJECTION RELATED REACTION 6
547 INJECTION SITE PARAESTHESIA 6
548 INTENTIONAL DOSE OMISSION 6
549 LIGAMENT SPRAIN 6
550 MELAENA 6
551 MENISCUS INJURY 6
552 MICTURITION URGENCY 6
553 MUSCULOSKELETAL DISORDER 6
554 PALLOR 6
555 PELVIC PAIN 6
556 POST PROCEDURAL COMPLICATION 6
557 PRODUCT ADMINISTRATION ERROR 6
558 PROSTATIC SPECIFIC ANTIGEN INCREASED 6
559 RED BLOOD CELL COUNT ABNORMAL 6
560 RENAL CANCER 6
561 SPONDYLITIS 6
562 STOMATITIS 6
563 THIRST 6
564 TOOTH DISORDER 6
565 URINARY INCONTINENCE 6
566 URINE ODOUR ABNORMAL 6
567 VENTRICULAR EXTRASYSTOLES 6
568 VENTRICULAR TACHYCARDIA 6
569 WEIGHT FLUCTUATION 6
570 AGITATION 5
571 ANGER 5
572 ANKLE FRACTURE 5
573 AST/ALT RATIO ABNORMAL 5
574 BILE ACIDS INCREASED 5
575 BLISTER RUPTURE 5
576 BLOOD CREATININE DECREASED 5
577 BLOOD GLUCOSE FLUCTUATION 5
578 BLOOD LACTATE DEHYDROGENASE INCREASED 5
579 BLOOD LOSS ANAEMIA 5
580 BLOOD POTASSIUM ABNORMAL 5
581 BLOOD POTASSIUM INCREASED 5
582 CAROTID ARTERIOSCLEROSIS 5
583 CARPAL TUNNEL SYNDROME 5
584 DEVICE DIFFICULT TO USE 5
585 DEVICE ISSUE 5
586 DIPLOPIA 5
587 DISCOURAGEMENT 5
588 EAR DISCOMFORT 5
589 EJECTION FRACTION DECREASED 5
590 EMBOLIC STROKE 5
591 ERUCTATION 5
592 EYE PRURITUS 5
593 FACIAL PAIN 5
594 FRACTURE 5
595 FRUSTRATION TOLERANCE DECREASED 5
596 GASTRIC ULCER 5
597 GASTRITIS 5
598 GASTRITIS EROSIVE 5
599 GASTROENTERITIS 5
600 GROIN PAIN 5
601 HAEMATURIA 5
602 HAIR TEXTURE ABNORMAL 5
603 HEART RATE ABNORMAL 5
604 HYPOXIA 5
605 INFUSION RELATED REACTION 5
606 INTERNATIONAL NORMALISED RATIO DECREASED 5
607 INTRAOCULAR PRESSURE INCREASED 5
608 JOINT INJURY 5
609 KIDNEY INFECTION 5
610 LIP DRY 5
611 MEAN CELL HAEMOGLOBIN CONCENTRATION ABNORMAL 5
612 METASTASES TO LIVER 5
613 MOOD ALTERED 5
614 MOUTH SWELLING 5
615 MULTIPLE SCLEROSIS 5
616 MUSCLE STRAIN 5
617 NERVE COMPRESSION 5
618 NEUROPATHIC ARTHROPATHY 5
619 NEUTROPHIL COUNT INCREASED 5
620 NIGHT SWEATS 5
621 ONYCHOCLASIS 5
622 ORAL HERPES 5
623 PANCREATITIS ACUTE 5
624 PAPULE 5
625 PLEURAL EFFUSION 5
626 PNEUMOTHORAX 5
627 POLYMYALGIA RHEUMATICA 5
628 PROCEDURAL PAIN 5
629 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 5
630 PROSTATOMEGALY 5
631 RASH PAPULAR 5
632 RAYNAUD^S PHENOMENON 5
633 ROAD TRAFFIC ACCIDENT 5
634 SARS-COV-2 TEST POSITIVE 5
635 SERUM FERRITIN ABNORMAL 5
636 SERUM FERRITIN INCREASED 5
637 SKIN HAEMORRHAGE 5
638 SUICIDAL IDEATION 5
639 SYRINGE ISSUE 5
640 THYROID DISORDER 5
641 TRIGGER FINGER 5
642 UPPER GASTROINTESTINAL HAEMORRHAGE 5
643 URINE ABNORMALITY 5
644 UTERINE HAEMORRHAGE 5
645 VISUAL ACUITY REDUCED 5
646 WRONG PRODUCT ADMINISTERED 5
647 ACUTE PULMONARY OEDEMA 4
648 AMYLOIDOSIS 4
649 ARTERIAL STENOSIS 4
650 ATAXIA 4
651 BEDRIDDEN 4
652 BLADDER DISCOMFORT 4
653 BLADDER PAIN 4
654 BLINDNESS TRANSIENT 4
655 BLINDNESS UNILATERAL 4
656 BLOOD IRON DECREASED 4
657 BLOOD TEST ABNORMAL 4
658 CARDIAC MURMUR 4
659 CARDIOVASCULAR DISORDER 4
660 CHOLECYSTITIS 4
661 COLITIS ULCERATIVE 4
662 COVID-19 PNEUMONIA 4
663 DECREASED IMMUNE RESPONSIVENESS 4
664 DERMATITIS ALLERGIC 4
665 DIABETIC KETOACIDOSIS 4
666 DIARRHOEA HAEMORRHAGIC 4
667 DIZZINESS POSTURAL 4
668 DRUG ERUPTION 4
669 ELECTRIC SHOCK SENSATION 4
670 ERYTHEMA MULTIFORME 4
671 FEAR 4
672 FOOD ALLERGY 4
673 FOREIGN BODY SENSATION IN EYES 4
674 GASTRIC DISORDER 4
675 GUILLAIN-BARRE SYNDROME 4
676 HAEMORRHOIDS 4
677 HEMIPLEGIA 4
678 HEPATOMEGALY 4
679 HICCUPS 4
680 HOSPITALISATION 4
681 HYPERCHOLESTEROLAEMIA 4
682 IMPAIRED QUALITY OF LIFE 4
683 INAPPROPRIATE SCHEDULE OF PRODUCT DISCONTINUATION 4
684 INJECTION SITE CELLULITIS 4
685 INJECTION SITE EXFOLIATION 4
686 INTERVERTEBRAL DISC PROTRUSION 4
687 INTESTINAL OBSTRUCTION 4
688 ISCHAEMIC STROKE 4
689 JOINT RANGE OF MOTION DECREASED 4
690 LIMB INJURY 4
691 LIPOPROTEIN (A) DECREASED 4
692 LIPOPROTEIN INCREASED 4
693 LOSS OF LIBIDO 4
694 LOWER LIMB FRACTURE 4
695 MATERNAL EXPOSURE BEFORE PREGNANCY 4
696 MENTAL IMPAIRMENT 4
697 MOOD SWINGS 4
698 MOUTH ULCERATION 4
699 MUSCULOSKELETAL PAIN 4
700 NEOPLASM 4
701 NOCTURIA 4
702 ORTHOSTATIC HYPOTENSION 4
703 OSTEOMYELITIS 4
704 OSTEOPENIA 4
705 PERFORMANCE STATUS DECREASED 4
706 PERIPHERAL COLDNESS 4
707 PIGMENTATION DISORDER 4
708 PNEUMONIA BACTERIAL 4
709 PRODUCT COLOUR ISSUE 4
710 PRODUCT PRESCRIBING ISSUE 4
711 PRODUCT QUALITY ISSUE 4
712 PRODUCT USE COMPLAINT 4
713 PSORIATIC ARTHROPATHY 4
714 RED BLOOD CELL SEDIMENTATION RATE INCREASED 4
715 RESPIRATORY TRACT IRRITATION 4
716 RHINITIS 4
717 ROTATOR CUFF SYNDROME 4
718 SCRATCH 4
719 SELF-INJURIOUS IDEATION 4
720 SENSORY LOSS 4
721 SHOCK 4
722 SINUS CONGESTION 4
723 SINUS PAIN 4
724 SKIN PLAQUE 4
725 SKULL FRACTURE 4
726 SPINAL OSTEOARTHRITIS 4
727 STEVENS-JOHNSON SYNDROME 4
728 SUDDEN HEARING LOSS 4
729 SUPRAVENTRICULAR TACHYCARDIA 4
730 THERAPEUTIC RESPONSE UNEXPECTED 4
731 THYROID MASS 4
732 TONGUE DISCOMFORT 4
733 UPPER LIMB FRACTURE 4
734 UROSEPSIS 4
735 WHITE BLOOD CELL COUNT DECREASED 4
736 WOUND INFECTION 4
737 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 4
738 ABDOMINAL TENDERNESS 3
739 ABNORMAL DREAMS 3
740 ACCIDENT 3
741 ACUTE HEPATIC FAILURE 3
742 ADVERSE EVENT 3
743 AGEUSIA 3
744 AGGRESSION 3
745 ALBUMIN URINE PRESENT 3
746 AMYLASE INCREASED 3
747 ANTINUCLEAR ANTIBODY POSITIVE 3
748 AORTIC ARTERIOSCLEROSIS 3
749 APOLIPOPROTEIN A-I DECREASED 3
750 APOLIPOPROTEIN A-I INCREASED 3
751 APOLIPOPROTEIN E INCREASED 3
752 APPENDICITIS 3
753 APPLICATION SITE PRURITUS 3
754 ARTERIAL DISORDER 3
755 ARTHRITIS REACTIVE 3
756 ARTHROPOD STING 3
757 ASCITES 3
758 BACTERIAL INFECTION 3
759 BASAL GANGLIA INFARCTION 3
760 BILE DUCT STONE 3
761 BILIRUBIN CONJUGATED INCREASED 3
762 BLOOD CALCIUM DECREASED 3
763 BLOOD CALCIUM INCREASED 3
764 BLOOD HOMOCYSTEINE INCREASED 3
765 BONE DISORDER 3
766 BREAST CANCER RECURRENT 3
767 BREATH SOUNDS ABNORMAL 3
768 BRONCHIECTASIS 3
769 BRONCHITIS CHRONIC 3
770 CALCINOSIS 3
771 CANDIDA INFECTION 3
772 CARDIAC VENTRICULAR THROMBOSIS 3
773 CARDIO-RESPIRATORY ARREST 3
774 CARDIOMEGALY 3
775 CAROTID ARTERY OCCLUSION 3
776 CELLULITIS GANGRENOUS 3
777 CEREBRAL DISORDER 3
778 CEREBRAL HAEMATOMA 3
779 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 3
780 COMA 3
781 COORDINATION ABNORMAL 3
782 CORONARY ARTERY RESTENOSIS 3
783 CORTISOL INCREASED 3
784 CYSTITIS INTERSTITIAL 3
785 DECREASED ACTIVITY 3
786 DROOLING 3
787 EMOTIONAL DISORDER 3
788 ENDOMETRIAL CANCER 3
789 EPIGASTRIC DISCOMFORT 3
790 EPILEPSY 3
791 EXPIRED PRODUCT ADMINISTERED 3
792 FACIAL DISCOMFORT 3
793 FACIAL PARALYSIS 3
794 FAECES HARD 3
795 FAECES SOFT 3
796 FEMUR FRACTURE 3
797 FLANK PAIN 3
798 FUNCTIONAL GASTROINTESTINAL DISORDER 3
799 FURUNCLE 3
800 GASTROINTESTINAL INFLAMMATION 3
801 GASTROINTESTINAL SOUNDS ABNORMAL 3
802 GLAUCOMA 3
803 GYNAECOMASTIA 3
804 HAEMOGLOBIN INCREASED 3
805 HAND FRACTURE 3
806 HELICOBACTER INFECTION 3
807 HEPATIC ENZYME ABNORMAL 3
808 HEPATIC FAILURE 3
809 HEPATITIS E 3
810 HEPATOTOXICITY 3
811 HIP FRACTURE 3
812 HYPERVOLAEMIA 3
813 HYPOTONIA 3
814 INFLAMMATORY BOWEL DISEASE 3
815 INJECTION SITE DRYNESS 3
816 INJECTION SITE INDURATION 3
817 INJECTION SITE ULCER 3
818 INTERNATIONAL NORMALISED RATIO ABNORMAL 3
819 INTERNATIONAL NORMALISED RATIO INCREASED 3
820 JOINT DISLOCATION 3
821 JOINT EFFUSION 3
822 KETOACIDOSIS 3
823 LIGAMENT RUPTURE 3
824 LIPOMA 3
825 LOCALISED INFECTION 3
826 LOCALISED OEDEMA 3
827 LYMPHOMA 3
828 MITRAL VALVE CALCIFICATION 3
829 MONOCYTE COUNT INCREASED 3
830 MOTOR DYSFUNCTION 3
831 NEAR DEATH EXPERIENCE 3
832 NECK INJURY 3
833 NECROTISING MYOSITIS 3
834 NERVE INJURY 3
835 NON-SMALL CELL LUNG CANCER 3
836 OBESITY 3
837 ORAL CANDIDIASIS 3
838 ORAL DISCOMFORT 3
839 ORAL MUCOSAL ERUPTION 3
840 ORAL PAIN 3
841 OVERDOSE 3
842 PAIN OF SKIN 3
843 PARANASAL SINUS HYPERSECRETION 3
844 PARANEOPLASTIC SYNDROME 3
845 PERICARDIAL EFFUSION 3
846 PETECHIAE 3
847 PHARYNGEAL PARAESTHESIA 3
848 PHOTOPHOBIA 3
849 PLANTAR FASCIITIS 3
850 PLASMA CELL MYELOMA 3
851 PNEUMONITIS 3
852 POLYMYOSITIS 3
853 POST-TRAUMATIC STRESS DISORDER 3
854 PREALBUMIN INCREASED 3
855 PRODUCT ADMINISTERED BY WRONG PERSON 3
856 PRODUCT PHYSICAL CONSISTENCY ISSUE 3
857 PROSTATE CANCER METASTATIC 3
858 PROSTATITIS 3
859 PROTEIN TOTAL DECREASED 3
860 PULMONARY FIBROSIS 3
861 PULMONARY PAIN 3
862 RECTAL CANCER 3
863 RED BLOOD CELL COUNT DECREASED 3
864 RENAL INJURY 3
865 RESPIRATORY ARREST 3
866 RETINAL DETACHMENT 3
867 SENSATION OF FOREIGN BODY 3
868 SERUM FERRITIN DECREASED 3
869 SHOULDER FRACTURE 3
870 SINUS BRADYCARDIA 3
871 SINUS NODE DYSFUNCTION 3
872 SKIN DISCOMFORT 3
873 SKIN FISSURES 3
874 SKIN MASS 3
875 SLUGGISHNESS 3
876 SPINAL DISORDER 3
877 STAPHYLOCOCCAL INFECTION 3
878 STAPHYLOCOCCAL SEPSIS 3
879 STENT PLACEMENT 3
880 TEMPERATURE INTOLERANCE 3
881 THERAPY CESSATION 3
882 THERAPY INTERRUPTED 3
883 THERAPY PARTIAL RESPONDER 3
884 THINKING ABNORMAL 3
885 THYROID HORMONES INCREASED 3
886 TONGUE DISCOLOURATION 3
887 TONGUE ULCERATION 3
888 TOOTH INFECTION 3
889 TRICUSPID VALVE INCOMPETENCE 3
890 ULCER 3
891 UNDERDOSE 3
892 URINE OUTPUT DECREASED 3
893 URTICARIA CHRONIC 3
894 VARICES OESOPHAGEAL 3
895 VITREOUS DETACHMENT 3
896 WEIGHT BEARING DIFFICULTY 3
897 ABNORMAL BEHAVIOUR 2
898 ABNORMAL ORGAN GROWTH 2
899 ACCIDENTAL OVERDOSE 2
900 ACNE 2
901 ACTIVITIES OF DAILY LIVING DECREASED 2
902 ACUTE MYELOID LEUKAEMIA 2
903 ADMINISTRATION SITE PAIN 2
904 ADRENAL ADENOMA 2
905 ALANINE AMINOTRANSFERASE ABNORMAL 2
906 ALBUMIN GLOBULIN RATIO INCREASED 2
907 AMYOTROPHIC LATERAL SCLEROSIS 2
908 ANAEMIA MACROCYTIC 2
909 ANAL INCONTINENCE 2
910 ANEURYSM 2
911 ANGIOPATHY 2
912 ANKYLOSING SPONDYLITIS 2
913 ANOSMIA 2
914 AORTIC DISSECTION 2
915 AORTIC OCCLUSION 2
916 AORTIC STENOSIS 2
917 AORTIC VALVE STENOSIS 2
918 APHTHOUS ULCER 2
919 APPETITE DISORDER 2
920 APPLICATION SITE HYPERSENSITIVITY 2
921 APPLICATION SITE RASH 2
922 APPLICATION SITE REACTION 2
923 AREFLEXIA 2
924 ATYPICAL PNEUMONIA 2
925 AUTOIMMUNE THYROIDITIS 2
926 AXILLARY PAIN 2
927 BASAL CELL CARCINOMA 2
928 BELL^S PALSY 2
929 BILE ACID MALABSORPTION 2
930 BLADDER CANCER 2
931 BLADDER PERFORATION 2
932 BLOOD BILIRUBIN UNCONJUGATED INCREASED 2
933 BLOOD BLISTER 2
934 BLOOD CHLORIDE DECREASED 2
935 BLOOD CHLORIDE INCREASED 2
936 BLOOD CHOLESTEROL 2
937 BLOOD CREATINE PHOSPHOKINASE ABNORMAL 2
938 BLOOD CREATININE ABNORMAL 2
939 BLOOD DISORDER 2
940 BLOOD LACTIC ACID INCREASED 2
941 BLOOD PRESSURE DIASTOLIC INCREASED 2
942 BLOOD PRESSURE INADEQUATELY CONTROLLED 2
943 BLOOD SODIUM INCREASED 2
944 BLOOD TESTOSTERONE DECREASED 2
945 BLOOD THYROID STIMULATING HORMONE ABNORMAL 2
946 BLOOD TRIGLYCERIDES 2
947 BODY HEIGHT DECREASED 2
948 BODY MASS INDEX INCREASED 2
949 BODY TEMPERATURE ABNORMAL 2
950 BRAIN INJURY 2
951 BRAIN NEOPLASM 2
952 BRAIN OEDEMA 2
953 BREAST DISORDER 2
954 BRONCHITIS VIRAL 2
955 CARBOHYDRATE ANTIGEN 19-9 INCREASED 2
956 CARBOHYDRATE TOLERANCE INCREASED 2
957 CARBON DIOXIDE INCREASED 2
958 CARCINOEMBRYONIC ANTIGEN INCREASED 2
959 CARDIAC PACEMAKER INSERTION 2
960 CARDIAC VALVE DISEASE 2
961 CARDIOGENIC SHOCK 2
962 CAROTID BRUIT 2
963 CAROTID INTIMA-MEDIA THICKNESS INCREASED 2
964 CEREBRAL ISCHAEMIA 2
965 CEREBRAL VASCULAR OCCLUSION 2
966 CERVICAL SPINAL STENOSIS 2
967 CERVICAL VERTEBRAL FRACTURE 2
968 CHANGE OF BOWEL HABIT 2
969 CHAPPED LIPS 2
970 CHOLANGITIS 2
971 CHONDROPATHY 2
972 COAGULATION TIME PROLONGED 2
973 COAGULOPATHY 2
974 COMPLETED SUICIDE 2
975 CONCOMITANT DISEASE PROGRESSION 2
976 CONCUSSION 2
977 CONNECTIVE TISSUE DISORDER 2
978 CORONARY ARTERIAL STENT INSERTION 2
979 CRANIOCEREBRAL INJURY 2
980 CREATINE KINASE MB INCREASED 2
981 CREATININE URINE INCREASED 2
982 CREPITATIONS 2
983 DELIVERY 2
984 DELUSION 2
985 DERMATITIS BULLOUS 2
986 DEVICE DEFECTIVE 2
987 DEVICE SAFETY FEATURE ISSUE 2
988 DIVERTICULUM INTESTINAL 2
989 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 2
990 DRUG RESISTANCE 2
991 DUODENAL ULCER 2
992 EAR CONGESTION 2
993 EAR DISORDER 2
994 ELECTROCARDIOGRAM ABNORMAL 2
995 ELECTROCARDIOGRAM Q WAVE ABNORMAL 2
996 ELECTROCARDIOGRAM ST-T SEGMENT ABNORMAL 2
997 ELECTROCARDIOGRAM T WAVE INVERSION 2
998 ENTERITIS 2
999 ENTHESOPATHY 2